MediGene, Memorial Sloan-Kettering Cancer Center deal

MDG signed an exclusive option to license chemotherapy-related intellectual property from Memorial Sloan-Kettering. MDG will use the IP in combination with its oncolytic herpes simplex virus (HSV) tec...